chartexchange

IKT
Inhibikase Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:50:01 PM EST
1.32USD-4.348%(-0.06)362,277
1.3200Bid1.3300Ask0.0100Spread
Loading…
Loading…
185.86M
Healthcare
Biotechnology
HQ
Atlanta, GA, USA
Previous Close
$1.38
Beta
1.67
52-Week High
$2.61 2026-09-03
52-Week Low
$1.36 2026-11-18
SMA 50
$1.83
SMA 200
$1.93
Avg. Vol 10D
518,885
Avg. Vol 30D
641,339
Avg. Vol 90D
617,709
Relative Vol
0.56
140.27M
171.64M
19,428,875
0.6700%
2,441
Jun 30, 2023 · 1-for-6 (reverse)
IKT Profile

inhibikase therapeutics, inc., a clinical stage pharmaceutical company, develops therapeutics for parkinson's disease, and related disorders that arise inside and outside of the brain. the company's product candidates include ikt-148009, a c-abl protein kinase inhibitor for use in the treatment of parkinson's disease, dysphagia, and neurogenic constipation; and ikt-001pro, a prodrug of the anti-cancer agent imatinib that is in preclinical development to minimize gastrointestinal side effects. it offers products comprise ikt-01427, a product candidate that blocks the causative virus of progressive multifocal leukoencephalopathy from replicating in the body; and ikt-148x series of portfolio compounds for use in the treatment of dementia with lewy body and multiple system atrophy. the company was founded in 2008 and is headquartered in atlanta, georgia.

IKT Performance
PeriodPriceDateChangeBeta
1W1.532026-11-12-13.40%2.905
1M1.652026-10-19-19.45%2.742
3M2.452026-08-19-45.92%2.309
6M1.572026-05-19-15.61%1.715
1Y1.562025-11-19-15.06%1.667
2Y2.002024-11-19-33.75%—
5Y11.402021-11-19-88.38%0.989
IKT Stock Summary

Inhibikase Therapeutics, Inc. Common Stock (NASDAQ:IKT) stock price today is $1.33, and today's volume is 360,246. IKT is down 3.986% today. The 30 day average volume is 641,339. IKT market cap is $185.86M with 140.27M shares outstanding.